Therapeutic Potential of PARP Inhibitors in the Treatment of Metastatic Castration-Resistant Prostate Cancer

SIMPLE SUMMARY: In recent years, the development of sequencing techniques to reveal the genomic information of prostate cancer tumors has allowed for the emergence of targeted therapies. Genomic aberrations in tumor cells have become popular due to the successful development of PARP inhibitors, whic...

Descripción completa

Detalles Bibliográficos
Autores principales: Jang, Albert, Sartor, Oliver, Barata, Pedro C., Paller, Channing J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700539/
https://www.ncbi.nlm.nih.gov/pubmed/33233320
http://dx.doi.org/10.3390/cancers12113467

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7700539/
https://www.ncbi.nlm.nih.gov/pubmed/33233320
http://dx.doi.org/10.3390/cancers12113467

Ejemplares similares